BNT162b2 antigen dose and SARS-CoV-2 omicron infection in adolescents
- PMID: 36738760
- PMCID: PMC9891733
- DOI: 10.1016/S1473-3099(23)00005-1
BNT162b2 antigen dose and SARS-CoV-2 omicron infection in adolescents
Conflict of interest statement
AAB has received institutional grant funding from Gilead Sciences unrelated to the work presented in this Correspondence. All other authors declare no competing interests. HC and LJA-R accessed and verified the raw data used in this study; not all authors were permitted to access the data used in this study because of privacy and confidentiality laws. We are grateful for support from the Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core at Weill Cornell Medicine–Qatar; the Qatar Ministry of Public Health; Hamad Medical Corporation; and Sidra Medicine. We are also grateful for the Qatar Genome Programme and Qatar University Biomedical Research Center for institutional support for the reagents needed for the viral genome sequencing.
Figures
References
-
- Lopez Bernal JA, Andrews N, Amirthalingam G. The use of quasi-experimental designs for vaccine evaluation. Clin Infect Dis. 2019;68:1769–1776. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
